Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets

Drug Development and Industrial Pharmacy

Volumn 26, Issue 6, 2000, Pages 681-686

  Yan, Guang ^a   Li, Henan ^a   Zhang, Ruhua ^a   Ding, Derong ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 6000; METHYLCELLULOSE; NIFEDIPINE;

ANIMAL EXPERIMENT; ARTICLE; DOG; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SCREENING; NONHUMAN; SUSTAINED RELEASE PREPARATION; VISCOSITY;

ABSORPTION; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DOGS; INJECTIONS, INTRAVENOUS; LACTOSE; METHYLCELLULOSE; NIFEDIPINE; OXAZINES; TABLETS;

EID: 0034107381     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100101284     Document Type: Article

References (10)

1. T. S. Foster, S. R. Hamann, et al., J. Clin. Pharmacol., 23, 161-170 (1983).
2. J. S. Grundy and R. T. Foster, Clin. Pharmacokinet., 30(10), 28-51 (1996).
3. T. Nishiata, Int. J. Pharm., 40, 125-128 (1987).
4. T. Nishiata, Y. Hirotani, et al., Int. J. Pharm., 42, 257-260 (1988).
5. A. C. Shah, N. J. Britten, et al., J. Controlled Release, 9, 169-174 (1989).
6. N. Kohri, K. Miyazaki, et al., Chem. Pharm. Bull., 35(6), 2504-2509 (1987).
7. J. Tu, P. Wang, et al., Zhongguo Yiyao Gongye Zazhi, 27(12), 539-542 (1996).
8. K. Tahara, K. Yamamoto, et al., J. Controlled Release, 35, 59-66 (1995).
9. M. Rowaland and G. Tucker, Pharmacokinetics: Theory and Methodology, pp. 390-391.
10. C. H. Kleinbloesem, J. Van Harten, et al., Clin. Pharmacol. Ther., 35, 742-749 (1984).